Total expenditure rose 21% YoY to Rs 480.73 crore during the quarter.
Profit before tax in Q3 FY22 stood at Rs 184.09 crore, up 2% from Rs 180.26 crore recorded in Q3 FY21. Current tax outgo in the third quarter was Rs 54.85 crore (up 44.7% YoY).
Pfizer is a research-based global biopharmaceutical company which is engaged in the discovery, development and manufacture of healthcare products.
The scrip fell 1.95% to currently trade at Rs 4477 on the BSE.
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
